Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:CRY

CryoLife (CRY) Stock Price, News & Analysis

CryoLife logo

About CryoLife Stock (NYSE:CRY)

Key Stats

Today's Range
N/A
50-Day Range
$17.19
$21.72
52-Week Range
N/A
Volume
7,792 shs
Average Volume
198,221 shs
Market Capitalization
$703.22 million
P/E Ratio
596.20
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

CryoLife, Inc. engages in the manufacture, process and distribution of medical devices and implantable human tissues. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes revenues from sales of BioGlue products, aortic stents and stent grafts, On-X products, CardioGenesis cardiac laser therapy, PerClot, and PhotoFix. The Preservation Services segment focuses on revenues from preservation of cardiac and vascular implantable human tissues. The company was founded on January 19, 1984 and is headquartered in Kennesaw, GA.

Receive CRY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CryoLife and its competitors with MarketBeat's FREE daily newsletter.

CRY Stock News Headlines

Buy this Stock before Trump Takes Office!
To make sure everyone has the opportunity to get in, closes for good at midnight on January 1st, we're lowering the price of Behind the Markets to just $19 for the whole year! And with a full 30-day money back guarantee, you have nothing to lose.
Artivion price target raised to $35 from $32 at Lake Street
Artivion (AORT) Receives a Buy from Lake Street
See More Headlines

CRY Stock Analysis - Frequently Asked Questions

CryoLife, Inc. (NYSE:CRY) released its quarterly earnings data on Thursday, November, 4th. The medical equipment provider reported $0.26 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.22. The medical equipment provider earned $72.21 million during the quarter, compared to analysts' expectations of $72.90 million. CryoLife had a net margin of 0.63% and a trailing twelve-month return on equity of 4.24%.

CryoLife subsidiaries include these companies: JOTEC AG, On-X Life Technologies Inc., Hemosphere, Cardiogenesis Corporation, AuraZyme Pharmaceuticals Inc., CryoLife Asia Pacific PTE. Ltd., CryoLife Canada Inc., and more.

Based on aggregate information from My MarketBeat watchlists, some other companies that CryoLife investors own include Energy Transfer (ET), Johnson & Johnson (JNJ), AT&T (T), Meta Platforms (META), Gilead Sciences (GILD), International Business Machines (IBM) and Netflix (NFLX).

Company Calendar

Last Earnings
11/04/2021
Today
12/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
Health Care Equipment
CUSIP
22890310
Employees
1,200
Year Founded
1984

Profitability

Net Income
$-16,680,000.00
Pretax Margin
0.41%

Debt

Sales & Book Value

Annual Sales
$253.23 million
Book Value
$8.46 per share

Miscellaneous

Free Float
37,560,000
Market Cap
$703.22 million
Optionable
Optionable
Beta
1.53

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NYSE:CRY) was last updated on 12/28/2024 by MarketBeat.com Staff
From Our Partners